![[Feedback]](/icons/banner/feedbackACT.gif){kind=icon}
![[For Subscribers]](/icons/banner/subscriberACT.gif){kind=icon}
![[Archive]](/icons/banner/archiveACT.gif){kind=icon}
![[Search]](/icons/banner/searchACT.gif){kind=icon}
![[Contents]](/icons/banner/tocACT.gif){kind=icon}
|
|
|
|
|
||
KW Gee and NC Lan
Department of Molecular Pharmacology and Toxicology, School of Pharmacy, University of Southern California, Los Angeles 90033.
Regional differences in neuroactive steroid modulation of the gamma- aminobutyric acidA receptor-chloride ionophore complex (GBRC), as measured by t-butylbicyclophosphoro[35S]thionate ([35S] TBPS) binding and 36Cl- uptake, were demonstrated in rat spinal cord versus frontal cortex. The rank order of potencies of a series of 5 alpha- and 5 beta- reduced isomers of 3 alpha-hydroxylated steroids against [35S]TBPS binding were different between regions. The differences in rank order of potencies imply the possible existence of heterogeneous populations of GBRC-coupled steroid recognition sites. The relative potencies of selected 5 alpha- and 5 beta-reduced isomers as potentiators of 36Cl- uptake paralleled their potencies as inhibitors of [35S]TBPS binding. Differential sensitivity of the steroid recognition site to the allosteric influence of gamma-aminobutyric acid was also demonstrated. It appears that regionally specific responses to GBRC-active steroids do occur, although the functional consequences of these effects await evaluation in appropriate in vivo models.
This article has been cited by other articles:
|
|
 |
|
  K. M. Wohlfarth, M. T. Bianchi, and R. L. Macdonald Enhanced Neurosteroid Potentiation of Ternary GABAA Receptors Containing the delta Subunit J. Neurosci., March 1, 2002; 22(5): 1541 - 1549. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. Nadeson and C. S. Goodchild Antinociceptive properties of neurosteroids III: experiments with alphadolone given intravenously, intraperitoneally, and intragastrically Br. J. Anaesth., May 1, 2001; 86(5): 704 - 708. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Feigenspan, S. Gustincich, and E. Raviola Pharmacology of GABAA Receptors of Retinal Dopaminergic Neurons J Neurophysiol, October 1, 2000; 84(4): 1697 - 1707. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. Haage and S. Johansson Neurosteroid Modulation of Synaptic and GABA-Evoked Currents in Neurons From the Rat Medial Preoptic Nucleus J Neurophysiol, July 1, 1999; 82(1): 143 - 151. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 B. G. Xue, E. R. Whittemore, C. H. Park, R. M. Woodward, N. C. Lan, and K. W. Gee J. Pharmacol. Exp. Ther., June 1, 1997; 281(3): 1095 - 1101. [Abstract] [Full Text]
|
|
|
|
|
|
W. J. Zhu and S. Vicini Neurosteroid Prolongs GABAA Channel Deactivation by Altering Kinetics of Desensitized States J. Neurosci., June 1, 1997; 17(11): 4022 - 4031. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. A. Finn, A. J. Roberts, F. Lotrich, and E. J. Gallaher Genetic Differences in Behavioral Sensitivity to a Neuroactive Steroid J. Pharmacol. Exp. Ther., February 1, 1997; 280(2): 820 - 828. [Abstract] [Full Text]
|
|
|
|
|
|
W. J. Zhu, J. F. Wang, K. E. Krueger, and S. Vicini delta Subunit Inhibits Neurosteroid Modulation of GABAA Receptors J. Neurosci., November 1, 1996; 16(21): 6648 - 6656. [Abstract] [Full Text] [PDF]
|
|
 |
 |
 |
|
 |
 |
 |
